Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
551 | 3 | CIRCULATING TUMOR CELLS//MASPIN//CANCER ASSOCIATED FIBROBLASTS | 18487 |
2466 | 2 | CHEMOSENSITIVITY TEST//HUMANIZED MICE//SCID MICE | 4221 |
17449 | 1 | PATIENT DERIVED XENOGRAFT//FP3//TUMORGRAFTS | 627 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PATIENT DERIVED XENOGRAFT | authKW | 726033 | 7% | 34% | 43 |
2 | FP3 | authKW | 351854 | 1% | 100% | 7 |
3 | TUMORGRAFTS | authKW | 292445 | 1% | 73% | 8 |
4 | PDX | authKW | 198392 | 2% | 26% | 15 |
5 | PLATINUMII DNA DAMAGE | authKW | 150794 | 0% | 100% | 3 |
6 | AFFILIATED ZHUJI HOSP | address | 129245 | 1% | 43% | 6 |
7 | L1210 DEGREES LEUKEMIA | authKW | 100530 | 0% | 100% | 2 |
8 | MAXILLIO IAL SURG | address | 100530 | 0% | 100% | 2 |
9 | PATIENT DERIVED CELLS | authKW | 100530 | 0% | 100% | 2 |
10 | ZHEJIANG CANC HOSP | address | 96657 | 1% | 38% | 5 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 8900 | 61% | 0% | 384 |
2 | Pathology | 254 | 6% | 0% | 39 |
3 | Cell Biology | 200 | 11% | 0% | 69 |
4 | Medicine, Research & Experimental | 200 | 8% | 0% | 49 |
5 | Urology & Nephrology | 103 | 4% | 0% | 28 |
6 | CYTOLOGY & HISTOLOGY | 54 | 0% | 0% | 3 |
7 | Otorhinolaryngology | 15 | 1% | 0% | 9 |
8 | Pharmacology & Pharmacy | 14 | 6% | 0% | 35 |
9 | Biotechnology & Applied Microbiology | 7 | 3% | 0% | 19 |
10 | Endocrinology & Metabolism | 6 | 3% | 0% | 16 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | AFFILIATED ZHUJI HOSP | 129245 | 1% | 43% | 6 |
2 | MAXILLIO IAL SURG | 100530 | 0% | 100% | 2 |
3 | ZHEJIANG CANC HOSP | 96657 | 1% | 38% | 5 |
4 | UNITE RECH TRANSLAT | 67018 | 0% | 67% | 2 |
5 | 5CENTER HLTH INFORMAT BIOINFORMAT | 50265 | 0% | 100% | 1 |
6 | ADV TECHNOL PARTNERSHIP INITIAT | 50265 | 0% | 100% | 1 |
7 | BEIJING CANC HOSP THORAC MED ONCOL | 50265 | 0% | 100% | 1 |
8 | BELFER PL CANC SCI DERMATOL | 50265 | 0% | 100% | 1 |
9 | BIOIMAGING BIL | 50265 | 0% | 100% | 1 |
10 | BREAST BIOL GRPMANCHESTER CANC | 50265 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | EXPERIMENTAL CELL BIOLOGY | 6098 | 1% | 2% | 7 |
2 | CLINICAL CANCER RESEARCH | 3331 | 5% | 0% | 32 |
3 | ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY | 2791 | 0% | 6% | 1 |
4 | ONCOTARGET | 1599 | 4% | 0% | 23 |
5 | CANCER RESEARCH | 1434 | 5% | 0% | 34 |
6 | HORMONES & CANCER | 1193 | 0% | 1% | 2 |
7 | NATURE REVIEWS CANCER | 1137 | 1% | 0% | 5 |
8 | MOLECULAR ONCOLOGY | 965 | 1% | 0% | 4 |
9 | NATURE REVIEWS CLINICAL ONCOLOGY | 952 | 0% | 1% | 3 |
10 | INVESTIGATIVE UROLOGY | 918 | 0% | 1% | 2 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PATIENT DERIVED XENOGRAFT | 726033 | 7% | 34% | 43 | Search PATIENT+DERIVED+XENOGRAFT | Search PATIENT+DERIVED+XENOGRAFT |
2 | FP3 | 351854 | 1% | 100% | 7 | Search FP3 | Search FP3 |
3 | TUMORGRAFTS | 292445 | 1% | 73% | 8 | Search TUMORGRAFTS | Search TUMORGRAFTS |
4 | PDX | 198392 | 2% | 26% | 15 | Search PDX | Search PDX |
5 | PLATINUMII DNA DAMAGE | 150794 | 0% | 100% | 3 | Search PLATINUMII+DNA+DAMAGE | Search PLATINUMII+DNA+DAMAGE |
6 | L1210 DEGREES LEUKEMIA | 100530 | 0% | 100% | 2 | Search L1210+DEGREES+LEUKEMIA | Search L1210+DEGREES+LEUKEMIA |
7 | PATIENT DERIVED CELLS | 100530 | 0% | 100% | 2 | Search PATIENT+DERIVED+CELLS | Search PATIENT+DERIVED+CELLS |
8 | XENOGRAFT | 88086 | 9% | 3% | 54 | Search XENOGRAFT | Search XENOGRAFT |
9 | ANTIANGIOGENIC EFFECT | 83768 | 1% | 33% | 5 | Search ANTIANGIOGENIC+EFFECT | Search ANTIANGIOGENIC+EFFECT |
10 | HETEROTRANSPLANT | 75394 | 0% | 50% | 3 | Search HETEROTRANSPLANT | Search HETEROTRANSPLANT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |